Fingolimod

Common brands: Gilenya, Vitamin D, Fingolimod, Ampyra, Baclofen (Intrathecal)

Top reporter: Novartis Pharmaceuticals Corporation

Provitamin D2 Compound [EPC]Sphingosine 1-phosphate Receptor Modulator [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Potassium Channel Blocker [EPC]gamma-Aminobutyric Acid-ergic Agonist [EPC]
85,806
Total Reports
11,923
Serious Reports
1,237
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.44%)

Patient Demographics

Male
17,996
Female
63,299

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Fingolimod.

# Reaction Reports % of Total
1 FATIGUE 10,784
10.3%
2 MULTIPLE SCLEROSIS RELAPSE 7,711
7.4%
3 HEADACHE 7,248
6.9%
4 DIZZINESS 5,360
5.1%
5 WHITE BLOOD CELL COUNT DECREASED 3,985
3.8%
6 GAIT DISTURBANCE 3,827
3.7%
7 HYPOAESTHESIA 3,758
3.6%
8 LYMPHOCYTE COUNT DECREASED 3,548
3.4%
9 FALL 3,479
3.3%
10 NAUSEA 3,418
3.3%
11 DRUG INEFFECTIVE 3,138
3.0%
12 MALAISE 3,128
3.0%
13 MEMORY IMPAIRMENT 2,967
2.8%
14 PAIN 2,911
2.8%
15 CENTRAL NERVOUS SYSTEM LESION 2,898
2.8%
16 ASTHENIA 2,866
2.7%
17 HEART RATE DECREASED 2,637
2.5%
18 PAIN IN EXTREMITY 2,612
2.5%
19 VISUAL IMPAIRMENT 2,597
2.5%
20 DEPRESSION 2,579
2.5%
21 VISION BLURRED 2,572
2.5%
22 BACK PAIN 2,495
2.4%
23 MULTIPLE SCLEROSIS 2,409
2.3%
24 PARAESTHESIA 2,373
2.3%
25 FEELING ABNORMAL 2,326
2.2%
26 BALANCE DISORDER 2,320
2.2%
27 DYSPNOEA 2,234
2.1%
28 MUSCULAR WEAKNESS 2,203
2.1%
29 NASOPHARYNGITIS 2,038
2.0%
30 DIARRHOEA 1,995
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.